BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

NeuroPhage Pharmaceuticals, Inc. 

222 Third Street
Suite 3120
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-714-5468 Fax: 617-714-5469


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
NeuroPhage Pharmaceuticals, Inc. Discovers GAIM-Changing Molecules To Combat Alzheimer's Disease And Other Neurodegenerative Disorders 4/22/2014 8:51:01 AM    More...
Cambridge's NeuroPhage Pharmaceuticals, Inc. Locks In $17 Million Series D 3/25/2014 7:11:37 AM    More...
Hunting For Brain Plaques, NeuroPhage Pharmaceuticals, Inc. Makes An Unconventional Move 1/31/2014 7:34:39 AM    More...
NeuroPhage Pharmaceuticals, Inc. Awarded Second Grant From The Michael J. Fox Foundation For Parkinson's Disease Research 12/19/2013 9:50:57 AM    More...
NeuroPhage Pharmaceuticals, Inc. To Participate In World's First G8 Dementia Summit 12/3/2013 12:20:59 PM    More...
NeuroPhage Pharmaceuticals, Inc. Raises $6.4 Million in Additional Financing 5/6/2013 9:55:24 AM    More...
Antitope Announces Protein Deimmunisation Research Agreement With NeuroPhage Pharmaceuticals, Inc. 1/25/2013 9:49:17 AM    More...
NeuroPhage Pharmaceuticals, Inc. Extends Series B to $21.4 Million 3/8/2012 8:05:27 AM    More...
NeuroPhage Pharmaceuticals, Inc. Receives Michael J. Fox Foundation Funding for Parkinson's Disease Research 2/17/2012 7:38:28 AM    More...

//-->